Latest Developments in Imaging for Axial Disease in Psoriatic Arthritis
DOI:
https://doi.org/10.58931/crt.2025.2367Abstract
Axial disease in psoriatic arthritis (axPsA), affecting the sacroiliac joints (SIJ) and spine, is recognized as one of the domains in the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for psoriatic arthritis (PsA). Accurate recognition of this manifestation is crucial for comprehensive management of this disease. It is defined according to both clinical and imaging features. Clinically, inflammatory back pain (IBP) is a key feature; however, findings from a recent Canadian inception cohort study—Screening for Axial Spondyloarthritis in Psoriasis, Iritis, or Colitis Cohorts 1 and 2 (SASPIC1 and 2)—which included patients with psoriasis and undiagnosed back pain, showed no differences in the frequency of IBP or non-steroidal anti-inflammatory drug (NSAID) responsiveness between those diagnosed with axPsA and individuals with other causes of chronic back pain. Similarly, data from the global Axial Involvement in Psoriatic Arthritis (AXIS) cohort revealed only minor numerical differences in NSAID responsiveness or frequency of IBP, according to the ASAS criteria, between participants with and without axial involvement when evaluated by central reviewers. Recent post-hoc studies of clinical trials in PsA have attempted to identify axPsA according to a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) threshold of ≥4. However, MRI-based assessment of axPsA in a large European cohort of 581 PsA patients, recruited across 17 European registries within the EuroSpA network, indicated that a BASDAI ≥4 did not discriminate PsA patients with axial disease from those without. Moreover, only 25–45% of patients with radiographic features of axPsA have been reported to have IBP, with some patients being clinically perceived as asymptomatic. Additionally, axSpA-based IBP criteria have demonstrated limited specificity for axPsA. Studies using MRI have reported poor correlation between sacroiliitis on imaging and both the presence and type of back pain.
References
Callis Duffin K, Campanholo CB, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol. 2022;18(8):465-479. doi:10.1038/s41584-022-00798-0. Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB, et al. Author Correction: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol. 2022;18(12):734. doi:10.1038/s41584-022-00861-w DOI: https://doi.org/10.1038/s41584-022-00861-w
Maksymowych WP, Carmona R, Weber U, Aydin SZ, Yeung J, Ries J, et al. Features of axial spondyloarthritis in two multicenter cohorts of patients with psoriasis, uveitis, and colitis presenting with undiagnosed back pain. Arthritis Rheumatol. 2025;77(1):47-58. doi:10.1002/art.42967. Correction to: “Features of axial spondyloarthritis in two multicenter cohorts of patients with psoriasis, uveitis, and colitis presenting with undiagnosed back pain”. Arthritis Rheumatol. Published online July 14, 2025. doi:10.1002/art.43310 DOI: https://doi.org/10.1002/art.43310
Torgutalp M, Azevedo V, Baraliakos X, Van den Bosch F, Braun J, Cauli A, et al. Characteristics of patients with psoriatic arthritis presenting with axial involvement: results of a prospective international multicenter study (AXIS) [abstract]. Arthritis Rheumatol. 2024;76(suppl 9). https://acrabstracts.org/abstract/characteristics-of-patients-with-psoriatic-arthritis-presenting-with-axial-involvement-results-of-a-prospective-international-multicenter-study-axis/
Vladimirova N, Hadsbjerg AEF, Krabbe S, Ciurea A, Bubova K, Gregova M, et al. Sacroiliac joint involvement in psoriatic arthritis – MRI, radiographic and clinical findings in 581 European routine care patients. Arthritis Res Ther. 2025;27(1):185. Published 2025 Sep 29. doi:10.1186/s13075-025-03652-2 DOI: https://doi.org/10.1186/s13075-025-03652-2
Yap KS, Ye JY, Li S, Gladman DD, Chandran V. Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis. Ann Rheum Dis. 2018;77(11): 1573-1577. doi:10.1136/annrheumdis-2018-213334 DOI: https://doi.org/10.1136/annrheumdis-2018-213334
Haroon M, Gallagher P, FitzGerald O. Inflammatory back pain criteria perform well in subset of patients with active axial psoriatic arthritis but not among patients with established axial disease. Ann Rheum Dis. 2019;78: 1003-1004. doi:10.1136/annrheumdis-2018-214583 DOI: https://doi.org/10.1136/annrheumdis-2018-214583
Williamson L, Dockerty JL, Dalbeth N, McNally E, Ostlere S, Wordsworth BP. Clinical assessment of sacroiliitis and HLA- B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology (Oxford). 2004;43(1): 85-88. doi:10.1093/rheumatology/keg475 DOI: https://doi.org/10.1093/rheumatology/keg475
Maldonado-Ficco H, Sheane BJ, Thavaneswaran A, Chandran V, Gladman DD. Magnetic resonance imaging in psoriatic arthritis: a descriptive study of indications, features and effect on treatment change. J Clin Rheumatol. 2017;23(5): 243-245. doi:10.1097/RHU.0000000000000558 DOI: https://doi.org/10.1097/RHU.0000000000000558
Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis. 1998;57(3):135-140. doi:10.1136/ard.57.3.135 DOI: https://doi.org/10.1136/ard.57.3.135
Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, et al. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology (Oxford). 2020;59(6):1340-1346. doi:10.1093/rheumatology/kez457 DOI: https://doi.org/10.1093/rheumatology/kez457
Jadon DR, Sengupta R, Nightingale A, Lindsay M, Korendowych E, Robinson G, et al. Axial disease in psoriatic arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis. 2017;76(4):701-707. doi:10.1136/annrheumdis-2016-209853 DOI: https://doi.org/10.1136/annrheumdis-2016-209853
Proft F, Lüders S, Hunter T, Luna G, Rios Rodriguez V, Protopopov M, et al. Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study. Ann Rheum Dis. 2022;81(11):1534-1540. Published 2022 Oct 12. doi:10.1136/ard-2022-222562 DOI: https://doi.org/10.1136/ard-2022-222562
Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, et al. Axial disease in psoriatic arthritis: the presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort. Semin Arthritis Rheum. 2021;51(2):464-468. doi:10.1016/j.semarthrit.2021.03.007 DOI: https://doi.org/10.1016/j.semarthrit.2021.03.007
De Hooge M, Ishchenko A, De Craemer AS, Steinfeld S, Nzeusseu A, Elewaut D, et al. Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts. RMD Open. 2023;9(2):e002994. doi:10.1136/rmdopen-2023-002994 DOI: https://doi.org/10.1136/rmdopen-2023-002994
Braga MV, de Oliveira SC, Vasconcelos AHC, Rodrigues Lopes J, Leite de Macedo Filho C, Adeodato Ramos LM, et al. Prevalence of sacroiliitis and acute and structural changes on MRI in patients with psoriatic arthritis. Sci Rep. 2020;10(1):11580. Published 2020 Jul 14. doi:10.1038/s41598-020-68456-7 DOI: https://doi.org/10.1038/s41598-020-68456-7
Furer V, Levartovsky D, Wollman J, Wigler I, Paran D, Kaufman I, et al. Prevalence of non-radiographic sacroiliitis in patients with psoriatic arthritis: a real-life observational study. J Rheumatol. 2021;48(7):1014-1021. doi:10.3899/jrheum.200961 DOI: https://doi.org/10.3899/jrheum.200961
Diaz P, Feld J, Eshed I, Eder L. Characterising axial psoriatic arthritis: correlation between whole spine MRI abnormalities and clinical, laboratory and radiographic findings. RMD Open. 2022;8(1):e002011. doi:10.1136/rmdopen-2021-002011 DOI: https://doi.org/10.1136/rmdopen-2021-002011
Baraliakos X, Pournara E, Coates LC, Navarro-Compán V, Blanco R, O’Brien E, et al. Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort. Rheumatology (Oxford). 2024;63(1):85-92. doi:10.1093/rheumatology/kead162 DOI: https://doi.org/10.1093/rheumatology/kead162
Lambert RGW, Baraliakos X, Bernard SA, Carrino JA, Diekhoff T, Eshed I, et al. Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS–SPARTAN collaboration. Ann Rheum Dis. 2024;83(12):1628-1635. Published 2024 Nov 14. doi:10.1136/ard-2024-225882 DOI: https://doi.org/10.1136/ard-2024-225882
Lambert RGW, Tuite MJ. Recent advances and insights into imaging of axial spondyloarthritis. Skeletal Radiol. 2025;54(11):2315-2328. doi:10.1007/s00256-025-04899-1 DOI: https://doi.org/10.1007/s00256-025-04899-1
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Canadian Rheumatology Today
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
